相关实验视频
Updated: May 15, 2025

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
德克萨米他:在治疗骨关节炎方面是一个双刃剑
Karyna Tarasova1,2, Maria Belen Arteaga1,2, Angkana Kidtiwong1,2
1VETERM, Equine Surgery Unit, Centre for Equine Health and Research, Department for Small Animals and Horses, University of Veterinary Medicine Vienna, Vienna, Austria.
德克萨米他 (DEX) 暂时降低了骨关节炎冠状细胞的炎症,但也损害了细胞外基质的产生,并诱导衰老. 建议在关节内使用葡萄糖皮质体时谨慎使用.
科学领域:
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 葡萄糖皮质类药物是常见的骨关节炎治疗方法,但长期的安全性是一个问题.
- 调查德克萨米他 (DEX) 和三氨酸 (TA) 对细胞的影响对于了解它们的治疗潜力和风险至关重要.
研究的目的:
- 评估DEX和TA在胆红细胞中的抗炎作用和潜在的有害作用.
- 分析DEX对状细胞基因表达,增殖,新陈代谢,伤口愈合和衰老的影响.
主要方法:
- 在用DEX和TA治疗的炎症性淋巴细胞中评估炎症基因表达.
- 利用下一代测序,质谱和细胞分析 (增殖,衰老,亡) 来研究DEX效应.
- 分析了差异表达基因 (DEGs),并进行了途径分析.
主要成果:
- 一次的DEX剂量减少了软骨细胞中的炎症基因;TA没有影响.
- DEX暂时降低了炎症,但也降低了细胞外基质 (ECM) 生产,并在健康的红细胞中诱导衰老.
- 德克斯治疗改变了细胞循环和ECM平衡途径;高剂量减少了炎症性红细胞的亡.
结论:
- 德克斯提供暂时的抗炎功效,但存在风险,包括减少ECM的产生和诱导衰老.
- 观察到的有害影响需要在骨关节炎管理中对关节内葡萄糖皮质激素的使用保持谨慎.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...

